संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

bryant ranch prepack - trospium chloride (unii: 1e6682427e) (trospium - unii:t4y8ork057) - trospium chloride extended-release capsules are a muscarinic antagonist indicated for the treatment of overactive bladder (oab) with symptoms of urge urinary incontinence, urgency, and urinary frequency. trospium chloride extended-release capsules are contraindicated in patients with: teratogenic effects pregnancy category c: there are no adequate and well-controlled studies of trospium chloride extended-release capsules in pregnant women. trospium chloride extended-release capsules should be used during pregnancy only if the potential benefit to the patient outweighs the risk to the patient and fetus. women who become pregnant during trospium chloride extended-release capsules treatment are encouraged to contact their physician. trospium chloride was not teratogenic at statistically significant levels in rats or rabbits administered doses up to 200 mg/kg/day. this corresponds to systemic exposures up to approximately 16 and 32 times, respectively (based on auc), the clinical exposure at the maximum recommen

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

bryant ranch prepack - trospium chloride (unii: 1e6682427e) (trospium - unii:t4y8ork057) - trospium chloride tablets are a muscarinic antagonist indicated for the treatment of overactive bladder (oab) with symptoms of urge urinary incontinence, urgency, and urinary frequency. trospium chloride tablets are contraindicated in patients with: teratogenic effects pregnancy category c: there are no adequate and well-controlled studies of trospium chloride tablets in pregnant women. trospium chloride tablets should be used during pregnancy only if the potential benefit to the patient outweighs the risk to the patient and fetus. women who become pregnant during trospium chloride tablets treatment are encouraged to contact their physician. risk summary based on animal data, trospium chloride is predicted to have a low probability of increased risk of adverse developmental outcomes, above background risk. adverse developmental findings were not observed to correlate with dose in rats or in rabbits. no increased risk above background was observed in rats and rabbits treated at an exposure approximately equiv

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

auden mckenzie (pharma division) ltd - trospium chloride - film coated tablet - 20 milligram - drugs for urinary frequency and incontinence

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

teva b.v. - trospium chloride - film coated tablet - 20 milligram - trospium

कनाडा - अंग्रेज़ी - Health Canada

accel pharma inc - trospium chloride - tablet - 20mg - trospium chloride 20mg - antimuscarinics

इसराइल - अंग्रेज़ी - Ministry of Health

tec-o-pharm-libra ltd - trospium chloride - film coated tablets - trospium chloride 30 mg - trospium and analgesics - trospium and analgesics - for the treatment of vegetative bladder dysfunction accompanied by urgency and/or frequency and/or urinary incontinence.

इसराइल - अंग्रेज़ी - Ministry of Health

tec-o-pharm-libra ltd - trospium chloride - film coated tablets - trospium chloride 15 mg - trospium - trospium - for the treatment of vegetative bladder dysfunction accompanied by urgency and/or frequency and/or urinary incontinence.

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

glenmark pharmaceuticals europe limited - trospium chloride - film coated tablet - 20 milligram - drugs for urinary frequency and incontinence

कनाडा - अंग्रेज़ी - Health Canada

marcan pharmaceuticals inc - trospium chloride - tablet - 20mg - trospium chloride 20mg - antimuscarinics

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - trospium chloride - oral solution - 4mg/1ml